Clinical Data Announces Renewed DNA Sequencing Contract with MRC
News Jun 06, 2006
The Company's Cogenics division (formerly Lark Technologies) is UK based provider of DNA sequencing to pharmaceutical, biotech and academic institutes with a long history of working with the MRC.
Paul Tomlin, Director of European Operations, said, "We are very pleased to continue our relationship with the MRC and are confident of meeting the needs of MRC scientists across all 35 UK sites."
"Cogenics has over 17 years experience with DNA sequencing and other molecular biology services and as such is uniquely positioned to provide the best customer experience possible and to serve the needs of the MRC."
Cogenics provides comprehensive pharmacogenomics and molecular services to the scientific community with six sites across North America and Europe employing over 200 experienced scientists and other professionals.
Schizophrenics' Blood Contains RNA From More MicrobesNews
The blood of schizophrenia patients features genetic material from more types of microorganisms than that of people without the debilitating mental illness, research at Oregon State University has found. What’s not known is whether that’s a cause or effect of the severe, chronic condition that strikes about one person in 100.READ MORE
Faulty Gene Leads to Alcohol-Induced Heart FailureNews
A faulty gene interacts with alcohol to accelerate heart failure in susceptible patients, a study suggests. This dangerous interaction can occur even when only moderate amounts of alcohol have been consumed.READ MORE